Period of time: 2011年4期
Publisher: Palgrave Macmillan Ltd
Founded in: 1994
Total resources: 35
ISSN: 1478-565X
Subject: Q81 Bioengineering ( Biotechnology )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Journal of Commercial Biotechnology,volume 10,issue 4
Menu
Editorial: R&D in biotechnology – The management challenges
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.2003: What lessons for European biotechnology?
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.Biotechnology's special forces: Field-based medical science liaisons
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.The class of 2004: Human capital in biotechnology
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.By Hughes-Wilson Wills in (2004)
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.Biotech–pharma alliances: Strategies, structures and financing
By Tyebjee Tyzoon,Hardin Jill in (2004)
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.Biotechnology policy in European countries: An assessment
By Zechendorf Bernhard in (2004)
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.Singapore's biomedical science sector development strategy: Is it sustainable?
By Lim Lisa P L,Gregory Michael J in (2004)
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.The market of therapeutic recombinant proteins to 2010
Journal of Commercial Biotechnology,volume 10,issue 4 , Vol. 10, Iss. 4, 2004-06 , pp.